Rituximab in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine (SAKK 31/98)

Authors:
  • O(on behalf of the Swiss Group for Clinical Cancer Research (SAKK)
    on behalf of the Swiss Group for Clinical Cancer Research (SAKK)

Abstract
No abstract available

This publication has 11 references indexed in Scilit: